A Phase 2 Study of Nivolumab and Brentuximab Vedotin Consolidation After Autologous Stem Cell Transplantation in Patients with High-Risk Classical Hodgkin Lymphoma

Type of Cancer
Lymphoma

Site
Hackensack

Sponsor
City of Hope

Protocol Number
City of Hope COH 16378

To Learn More Call
(201)-510-0950